Plain-English translation of NCT06800768 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This trial is evaluating a new imaging technique called 68Ga-FAPI PET/CT to help detect whether thyroid cancer has returned or spread to other parts of the body after surgery. The scan is designed to be more sensitive and help doctors spot recurrent or metastatic disease earlier and more accurately than standard imaging methods.
After thyroid cancer surgery, doctors need reliable ways to detect if cancer has come back or spread. This study aims to see whether this newer imaging approach can find these problems more effectively and help guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo one specialized imaging scan (68Ga-FAPI PET/CT) when your doctor suspects your thyroid cancer may have recurred or spread. The researchers will collect basic information about you, review your medical history, and follow up with your scan results to compare them with other imaging or biopsy findings to evaluate how accurate the new scan is.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Enrollment target
~40 participants
Started
February 2025
Primary completion
January 2030
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiajia Hu
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.